Sample Briefing - March 2012 issue

This edition of the Chemical Watch European Business Briefing is available to download as part of our free trial package.

In this month's Briefing

Key articles:

  • Sean Milmo examines the debate about whether GLP is becoming too outdated to remain the only internationally accepted guidance for risk assessment;
  • Katia Filippova advises companies to watch out for the adoption of key technical regulations in Russia this year;
  • Geraint Roberts looks at recommendations to the Commission for a regulatory system for endocrine disrupters;
  • Tianjie Ma and Yixiu Wu outline Greenpeace's campaign priorities in China for chemicals;

Other features:

  • Philippa Jones reports from the European Commission's recent REACH/CLP enforcement workshop on calls for coordinated action among agencies within member states;
  • Laura Greenhalgh examines the evidence for a link between chemical exposure and obesity/diabetes;
  • Eric Xiong advises firms on how to cost-effectively notify new substances in China;
  • Philippa Jones hears from companies about the problems caused by a lack of validated testing methods for nanomaterials;
  • Elizabeth Grossman reports on the controversy surrounding a conditional registration in the US for two nanosilver products;
  • Joanne Hunter gauges reaction to guidance on the use of total diet studies to assess food contaminants;
  • In this month's CLP Clinic, REACHReady's Mark Selby gives advice on how to classify samples;
  • In the REACH Hub column, ReachCentrum's Isaline van der Straten W warns firms to be constantly prepared for their dossiers to be selected for evaluation;
  • In this month's Guest Column, Jim Willis explains why the UN's three principal chemicals conventions have been brought under a single secretariat.

The monthly PDF briefing is only available to registered users with a subscription or free trial. Follow this link to take a no-obligation 14 day free trial

Registered users: please log in using your Personal Access Code here:

Forgotten your access code? | Take a no-obligation 14 day free trial